New York Health Plan Association President and CEO calls A.663-A/S.7499-A, which requires drug manufacturers to provide at least 60 days notice of their intention to raise the cost of a drug more than 10%, “a sensible approach to protect consumers, boost transparency, and crack down on the egregious prices drug makers charge.”